Boston Trust Walden Corp Abbott Laboratories Transaction History

Boston Trust Walden Corp

  • $14.1 Billion
  • Q3 2024

A detailed history of Boston Trust Walden Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Boston Trust Walden Corp holds 46,445 shares of ABT stock, worth $5.47 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
46,445
Previous 46,795 0.75%
Holding current value
$5.47 Million
Previous $4.86 Million 8.91%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$100.07 - $118.13 $35,024 - $41,345
-350 Reduced 0.75%
46,445 $5.3 Million
Q2 2024

Jul 19, 2024
SELL
$100.73 - $112.44 $22,664 - $25,299
-225 Reduced 0.48%
46,795 $4.86 Million
Q1 2024

Apr 22, 2024
SELL
$109.52 - $120.96 $84,878 - $93,744
-775 Reduced 1.62%
47,020 $5.34 Million
Q4 2023

Jan 24, 2024
SELL
$90.19 - $110.4 $30,754 - $37,646
-341 Reduced 0.71%
47,795 $5.26 Million
Q3 2023

Oct 18, 2023
SELL
$95.53 - $114.62 $244,652 - $293,541
-2,561 Reduced 5.05%
48,136 $4.66 Million
Q2 2023

Jul 24, 2023
SELL
$100.78 - $112.29 $153,891 - $171,466
-1,527 Reduced 2.92%
50,697 $5.53 Million
Q1 2023

Apr 19, 2023
SELL
$96.86 - $114.01 $135,604 - $159,614
-1,400 Reduced 2.61%
52,224 $5.29 Million
Q4 2022

Jan 20, 2023
SELL
$95.06 - $111.52 $32,700 - $38,362
-344 Reduced 0.64%
53,624 $0
Q3 2022

Oct 19, 2022
SELL
$96.76 - $112.03 $68,699 - $79,541
-710 Reduced 1.3%
53,968 $5.22 Million
Q2 2022

Jul 22, 2022
SELL
$102.07 - $123.37 $48,993 - $59,217
-480 Reduced 0.87%
54,678 $5.94 Million
Q1 2022

Apr 20, 2022
SELL
$114.02 - $139.04 $351,865 - $429,077
-3,086 Reduced 5.3%
55,158 $6.53 Million
Q4 2021

Jan 21, 2022
BUY
$115.53 - $141.46 $88,264 - $108,075
764 Added 1.33%
58,244 $8.2 Million
Q3 2021

Oct 25, 2021
BUY
$116.66 - $129.06 $242,419 - $268,186
2,078 Added 3.75%
57,480 $6.79 Million
Q2 2021

Jul 22, 2021
BUY
$105.79 - $124.53 $5,183 - $6,101
49 Added 0.09%
55,402 $6.42 Million
Q1 2021

Apr 21, 2021
SELL
$108.84 - $128.23 $40,815 - $48,086
-375 Reduced 0.67%
55,353 $6.63 Million
Q4 2020

Jan 15, 2021
BUY
$105.0 - $114.42 $46,305 - $50,459
441 Added 0.8%
55,728 $6.1 Million
Q3 2020

Oct 14, 2020
SELL
$91.64 - $111.29 $34,365 - $41,733
-375 Reduced 0.67%
55,287 $6.02 Million
Q2 2020

Jul 23, 2020
SELL
$76.57 - $98.0 $38,131 - $48,804
-498 Reduced 0.89%
55,662 $5.09 Million
Q1 2020

Apr 21, 2020
SELL
$62.82 - $91.86 $159,499 - $233,232
-2,539 Reduced 4.33%
56,160 $4.43 Million
Q4 2019

Jan 10, 2020
SELL
$78.51 - $87.4 $101,591 - $113,095
-1,294 Reduced 2.16%
58,699 $5.1 Million
Q3 2019

Oct 21, 2019
SELL
$81.84 - $88.74 $30,608 - $33,188
-374 Reduced 0.62%
59,993 $5.02 Million
Q2 2019

Jul 25, 2019
BUY
$72.88 - $85.0 $8,599 - $10,030
118 Added 0.2%
60,367 $5.08 Million
Q1 2019

Apr 16, 2019
BUY
$66.22 - $80.06 $524,065 - $633,594
7,914 Added 15.12%
60,249 $4.82 Million
Q4 2018

Jan 17, 2019
SELL
$65.56 - $74.27 $3,015 - $3,416
-46 Reduced 0.09%
52,335 $3.79 Million
Q3 2018

Oct 23, 2018
BUY
$60.81 - $73.36 $51,627 - $62,282
849 Added 1.65%
52,381 $3.84 Million
Q2 2018

Jul 25, 2018
SELL
$57.57 - $63.54 $29,360 - $32,405
-510 Reduced 0.98%
51,532 $3.14 Million
Q1 2018

Apr 13, 2018
BUY
$56.27 - $63.62 $146,302 - $165,412
2,600 Added 5.26%
52,042 $3.12 Million
Q4 2017

Jan 29, 2018
SELL
$53.68 - $57.47 $39,615 - $42,412
-738 Reduced 1.47%
49,442 $2.82 Million
Q3 2017

Oct 13, 2017
BUY
$48.06 - $53.64 $2.41 Million - $2.69 Million
50,180
50,180 $2.68 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Boston Trust Walden Corp Portfolio

Follow Boston Trust Walden Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email